Next 10 |
2024-07-18 13:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. International equities...
2024-07-17 11:20:00 ET Summary During the quarter, we sold our position in Novartis and invested the proceeds in Roche. We decided to sell Novartis to fund the purchase of what we believe is a more optimal investment in Roche. Considering Roche's ~4% dividend yield and our pro...
2024-07-17 11:05:00 ET Summary For the second quarter of 2024, Aristotle Capital’s International Equity Composite posted a total return of -0.85% gross of fees (-0.96% net of fees). During the quarter, we sold our position in Novartis and invested the proceeds in Roche. ...
2024-07-16 15:31:42 ET More on The Cooper Companies Cooper Companies: Business Growth Noted, Valuations An Ask The Cooper Companies, Inc. (COO) Q2 2024 Earnings Call Transcript The Cooper Companies Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating ...
2024-07-16 09:45:00 ET Summary With inflation slowing in many countries, equity markets saw modest returns in Q2. In a cooling equity market, the portfolio fell short of the MSCI EAFE Index and the MSCI All Country World ex USA Index in Q2. Our holdings in the materials sector...
2024-07-15 18:16:58 ET More on STAAR Surgical STAAR Surgical: Keeping An Eye On The Shares STAAR Surgical Company (STAA) Q1 2024 Earnings Call Transcript STAAR Surgical gains amid takeover speculation STAAR Surgical pares earlier gain amid takeover speculatio...
2024-07-10 13:23:27 ET More on STAAR Surgical STAAR Surgical: Keeping An Eye On The Shares STAAR Surgical Company (STAA) Q1 2024 Earnings Call Transcript STAAR Surgical pares earlier gain amid takeover speculation, turns negative (update) STAAR Surgical Q1 20...
2024-07-10 08:25:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy lagged sl...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $91.69. So far today, approximately 136.09k shares have been exchanged, as compared to an average 30-day volume of 907.93k shares. Alcon Inc., an eye care company, researches, develops, manufactur...